AlphaAlign

Inflection Points · Issue 1 · A four-minute read

Inflection Points

The decision changes hands. That's where the value leaks.

Four inflection points decide most of a healthcare company's value. At each one, the commercial plan gets rebuilt by someone new.

Most healthcare companies hit the same four inflection points: an investment, a new leader, a growth reset and, eventually, an exit. Some add an acquisition along the way. We've lived them as CEOs, and we've been the people handed someone else's plan.

The pattern repeats. The deal team writes a thesis. Advisers build a diligence model. A new leader writes a 100-day plan. The board gets a deck.

Four documents, four owners, four versions of the truth.

By the numbersThe plan changes hands.

~2 in 3

private equity firms replace a portfolio company CEO during the hold. 83% of PE leaders say unplanned CEO turnover stretches the hold.

1.8 yrs

is the average tenure of a chief revenue officer, against about 4.3 years for a CEO. The owner of the revenue plan changes fastest.

Every one of those changes is a handoff, and every handoff is a chance for the plan to drift from the bet that justified it. When a CRO leaves at month 20, ask whether the plan and the bet had already split.

The fixOne loop that stays with the decision.

  • ResearchMap the market, the accounts and the people from public information, before anyone opens a data room.
  • JudgmentTurn it into a few decisions, with the realistic range of outcomes for each.
  • ActionGive every decision an owner, a date and a measure.
  • ReactionRecord what happened. Adjust the plan. Make the next call better.

SignalNew research. Updated priorities.

Last month, a small study tested a new way to follow up patients after a medical device company's procedure. One small study. But for anyone underwriting that market, it reorders the diligence questions.

A plan written the month before wouldn't know. One that keeps reading would. That's the difference between a report and a system.

For your next inflection pointThree questions to ask this week.

  1. Can you trace this quarter's top three actions back to the original thesis?
  2. Who owns the commercial picture between the deal team and the CEO?
  3. When results drift, when does the plan change: next week, or at the next board meeting?

If any answer is "I'm not sure," the plan is already drifting.

Facing an inflection point? Send the question.

Send the decision in front of you. You get a one-page Outside-in Read, built from public information, with the fee agreed in writing before work starts.

Request an Outside-in Read Subscribe by email

This is the work we do: healthcare commercial intelligence that stays with the decision, from the thesis through the first year of results. AI brings the reach and the rigor: it reads widely, maps the accounts and the people, and keeps the picture current as the market moves. Healthcare judgment makes the call. Together, they let the plan move between board meetings, ahead of the change instead of behind it.

The AlphaAlign team

Inflection Points is a monthly note on the commercial decisions that move healthcare companies. If it was useful, forward it to one person facing an inflection point.

Send a question